Introduction {#S0001}
============

Glaucoma is a neurodegenerative disease that leads to progressive loss of retinal ganglion cells, causing irreversible visual field defects.[@CIT0001]--[@CIT0003] It is the second leading cause of irreversible blindness in the world after cataract.[@CIT0004] Until now, the exact etiology of glaucoma is unknown, but it is clinically defined by the presence of characteristic changes in the optic disc and defects in the visual field correspondingly.[@CIT0005] It is affecting more than 60 million people over the world, disproportionately affecting mainly women and Asians.[@CIT0004],[@CIT0006] Glaucoma is a genetically heterogeneous disorder which results from the interaction between several genetic and environmental factors. Therefore, both genetic and environmental influences determine the risk of this disorder.[@CIT0007] Glaucoma has been classified into two major types according to its cause.[@CIT0008] The first type is the primary glaucoma which involved several subtypes. The most prevalent form is primary open angle glaucoma (POAG) which occurs at the age of 35 years and above. Secondly, primary congenital glaucoma (PCG) is considered the most prevalent childhood glaucoma that occurs in early infancy or at birth in the age up to 3 years. Moreover, it is a major cause of blindness in this young population and it is inherited commonly as an autosomal recessive trait. Thirdly, juvenile-onset open angle glaucoma (JOAG) occurs in early onset in the age of 10--35 years and it is inherited as autosomal dominant trait. Finally, primary angle closure glaucoma (PACG) is considered as the second prevalent form of glaucoma after POAG.[@CIT0009]

The second type of glaucoma is resulting from injury, inflammation, tumor, or in advanced cases of cataract or diabetes which called as secondary glaucoma.[@CIT0010] The main pathology in glaucoma is caused by elevated intraocular pressure (IOP). Several genetics studies including candidate genes, linkage analysis studies, and genome wide association studies (GWAS) have identified several loci associated with the development of POAG.[@CIT0007],[@CIT0011] A candidate gene study including *CYP1B1* gene suggested that the *CYP1B1* was involved in a proportion of POAG and PACG cases, and the similar haplotype background of mutations is indicative of their common origin across different glaucoma phenotypes.[@CIT0012] Classical linkage approaches in POAG families allowed the delineation of 14 loci (*GLC1A-1N*).[@CIT0013] Thus, glaucoma-associated genes have been identified in three of them including myocilin (*MYOC/GLC1A*),[@CIT0007] optineurin (*OPTN/GLC1E*),[@CIT0014] and WD repeat domain 36 (*WDR36/GLC1G*).[@CIT0015] Each of these genes is responsible for a small proportion of POAG cases (1--5%). In addition, heterozygous loss of function mutations in *CYP1B1* constitutes a risk factor for development of POAG.[@CIT0012],[@CIT0016]--[@CIT0018] Previous GWAS studies of advanced POAG identified two loci at *TMCO1* and *CDKN2B-AS1*.[@CIT0019] In addition, non-advanced POAG studies have implicated CAV1,[@CIT0020] *SIX6*, and a region at 8q22.[@CIT0011] Recently, a three-stage GWAS identified additional genetic loci associated with POAG in participant of European descent population. It identified three new loci associated with development of POAG; these loci are located upstream of *ABCA1*, within *AFAP1*, and within *GMDS*. All these genes are expressed within human retina, optic nerve, and trabecular meshwork.[@CIT0021]

These studies used different populations with different strategies, and all identified the same gene (*ABCA1)* which is involved in the regulation of cellular cholesterol, lipid metabolism, and playing a role in the eye disease. ABC subfamily are found exclusively in multicellular eukaryotes. *ABCA1* gene is mapped to position 9q31.1. It is highly expressed in human retina, optic nerve, trabecular meshwork, and retinal ganglion cells which have a role in the development of glaucoma.[@CIT0021]

The aim of this study was to investigate the allelic and genotypic distribution of SNPs in the *ABCA1* gene in Jordanian patients of Arab descent diagnosed with primary glaucoma and to investigate the association between the *ABCA1* gene polymorphisms and glaucoma among Jordanian patients of Arab descent.

Materials And Methods {#S0002}
=====================

Sample Study {#S0002-S2001}
------------

All subjects who participated in this case-control study were of Arab descent from North Jordan including 52 unrelated patients with primary glaucoma disease and 96 healthy individuals. Clinical and demographic data were extracted and collected from their medical records. The study was approved by the Institutional Review Board (IRB) (IRB\# 23/94/2016) of King Abdullah University Hospital (KAUH), Jordan. All control subjects were voluntarily involved and signed a written informed consent. All clinical investigations were conducted according to the principles expressed in the Declaration of Helsinki consent. This study was also conducted according to the provisions of the Human Ethics standard of Jordan University of Science and Technology. Blood samples of primary glaucoma patients were collected from King Abdullah University Hospital (KAUH). The characteristics of the 52 glaucoma patients in this study were displayed in [Table 1](#T0001){ref-type="table"}.Table 1Characteristics Of 52 Glaucoma Patients Of Jordanian Arab Descent In This StudyCategoryValue N (%)**Demographic Data**Gender Male35 (67.3) Female17 (32.6)Age ≤35 years13 (25.0) \>35 years39 (75.0)**Clinical Data**Family History Yes18 (36.0) No32 (64.0)IOP ≤21 mmHg29 (58.0) \>21 mmHg21 (42.0)Optic disc status Normal4 (08.0) Damaged46 (92.0)**Eye Examination**Slit-lamp biomicroscopy Normal18 (40.9) Defect26 (59.1)Gonioscopy POAG39 (75.0) PCG13 (25.0)Automated visual field test Normal4 (8.50) Defected43 (91.5)

Genomic DNA Extraction {#S0002-S2002}
----------------------

Blood samples from control and glaucoma patients were drowned into EDTA tubes. Then, genomic DNA was extracted using the commercially available kit (Qiagen, Germany) according to the manufacturer's instructions. Briefly, 900 μL of RBC lysis solution was mixed with 300 μL of blood sample. Then, the mix was centrifuged at 16,000 rpm. 300 μL of cell lysis solution was then added to the pellet, followed by addition of 100 μL protein precipitation solution. Then, 300 μL isopropanol was added after centrifugation. The DNA was washed with 70% ethanol and dried at room temperature. Finally, 50 μL DNA rehydration solutions were added. DNA quantity and purity was verified (Bio-Drop Spectrophotometer, Cambridge, UK). The quality of the DNA samples was also evaluated on 2% agarose gel electrophoresis using the UV-light imager (Protein Simple, USA).

DNA Sequencing {#S0002-S2003}
--------------

PCR primers were designed to cover the coding sequences, plus a few nucleotides in the intron on both ends ([Table 2](#T0002){ref-type="table"}). Primer extension sequencing was performed by GENEWIZ, Inc. (South Plainfield, NJ, USA) using Applied Biosystems Big Dye version 3.1. Both forward and reverse strands were sequenced. The reactions were run on Applied Biosystem's 3730×L DNA Analyzer.Table 2The SNPs, SNPs Position And Primers Sequences For *ABCA1* GeneSNP-IDChrBpPrimer ForwardPrimer Reversers24724939107,695,848ATTTGACTGCAGTGGGTGAGTCAAGAGGTTAGCCTTGGCTrs24870329107,703,934TTTGCCTTTGCATGGTTTTACCAAACCCATAAGAGCCTGA[^1]

Sequencing Analyses {#S0002-S2004}
-------------------

The sequencing data were analysed with Lasergene SeqMan (DNASTAR, Madison, WI, USA). The resulting sequence were analysed by alignment of the standard reference sequence of each primer product and then comparing the resulted genotypes to the standard *ABCA1* gene reference sequence.

### Genotype Phenotype Association With Clinical Variable Data Of Glaucoma Patients {#S0002-S2004-S3001}

A group of statistical tests were conducted to show the association between genotype and phenotype of the two reported SNPs (rs2472493 and rs2487032) in the *ABCA1* gene by adjusting the clinical variable data including age, gender, family history, IOP, optic disc status, slit lamp biomicroscopy, gonioscopy, and automated visual field test in glaucoma patients. The schematic structure of the human *ABCA1* and the positions of the two SNPs genotyped in this study and their dbSNP IDs are also shown in [Figure 3](#F0003){ref-type="fig"}.

Statistical Analyses {#S0002-S2005}
--------------------

Data analysis was performed using SAS (Statistical Analysis System, version 9.2; SAS Institute, Cary, NC, USA). The genotype frequency was calculated and tested by using the Hardy-Weinberg Equilibrium equation (HWE). The allelic and genotypic association *p-*value was determined using Chi-squared test between cases and controls. Odds ratios were computed for each model (codominant, dominant, recessive, and overdominant) separately using SAS functions and SNPstats software (<https://www.snpstats.net>). The level of significance was considered at α = 0.05.

Results {#S0003}
=======

Sample Characteristics {#S0003-S2001}
----------------------

The study involved 52 Jordanian Arab patients with primary glaucoma disease and 96 healthy controls. A total of 52 Jordanian primary glaucoma patients fulfilled the exclusion criteria and consented to participate in this study. The frequency of allele and genotype for both SNPs in glaucoma patients and controls (Case/Control) are summarized in [Table 3](#T0003){ref-type="table"}. Among 52 primary glaucoma patients, about 39 (75%) of them were diagnosed with POAG with age \>35, while 13 (25%) of the patients were diagnosed with PCG with age ≤35 years. The males consist about 67.31% which compromise the large percent, while females consist only 32.69% of all patients. In the present study, the 52 Jordanian patients were diagnosed with primary glaucoma based on optic disc damage and visual field defects. IOP was more than 21 mmHg in 21 patients although some of them have been subjected to treatment. Patients with secondary causes of glaucoma (e.g. uveitis, steroid-induced, or trauma) were excluded from this study. We recruited 96 healthy controls and all were found to have no signs or symptoms of primary glaucoma or any other eye disease and did not have any family history of glaucoma.Table 3The Frequency Of Allele And Genotype For Both SNPs In Glaucoma Patients And Controls (case/control)SNP IDrs2472493Cases N (%) 52 (35.1)HWE *p-value*Controls N (%) 96 (64.9)HWE *p*-valueAllele T59(60.0)\^0.886124(65.0)\^0.507Allele C39(40.0)\^66(35.0)\^Genotype CC8(16.0)0.88610(11.0)0.507Genotype TC23(47.0)46(48.0)Genotype TT18(37.0)39(41.0)**rs2487032**Allele T55(56.0)\^0.742116(62.0)\^0.334Allele C43(44.0)\^72(38.0)\^Genotype CC10(20.0)0.74216(17.0)0.334Genotype TC23(47.0)40(43.0)Genotype TT16(33.0)38(40.0)[^2]

DNA Sequencing Results {#S0003-S2002}
----------------------

### SNPs Genotyping And Variation Detection Within *ABCA1* Gene {#S0003-S2002-S3001}

Two Single Nucleotide Polymorphisms SNPs were genotyped in order to check their presence in 52 Jordanian glaucoma patients. The resultant sequences (Electropherograms) were blasted against the reference sequence. Panel A shows a heterozygous rs2472493 sequence variant genotype, which shows both nucleotide T (red peak) and nucleotide C (blue peak); meanwhile, panel B shows the wild-type allele (T) of rs2472493 SNP for *ABCA1* gene. Moreover, panel C shows homozygous rs2472493 sequence variant genotype exhibiting the conversion of nucleotide T (red peak) to nucleotide C (blue peak) ([Figure 1](#F0001){ref-type="fig"}). The Partial Electropherogram sequences of rs2487032 SNP for *ABCA1* gene in glaucoma patients were shown ([Figure 2](#F0002){ref-type="fig"}). Briefly, Forward primer was used here in PCR sequencing step. Panel A shows homozygous rs2487032 sequence variant genotype exhibiting the conversion of nucleotide T (red peak) to nucleotide C (blue peak); meanwhile, panel B shows a heterozygous rs2487032 sequence variant genotype exhibiting both nucleotide T (red peak) and nucleotide C (blue peak). Finally, panel C shows the wild-type allele (T) of rs2487032 SNP for *ABCA1* gene.Figure 1Partial Electropherogram sequences of rs2472493 SNP for *ABCA1* gene in glaucoma patients. Forward primer was used here in PCR sequencing step. (**A**) A sample showing heterozygous rs2472493 sequence variant genotype, which shows both nucleotide T (red peak) and nucleotide C (blue peak). (**B**) The wild type allele (T) of rs2472493 SNP for *ABCA1* gene. (**C**) A sample showing homozygous rs2472493 sequence variant genotype, which shows the conversion of nucleotide T (red peak) to nucleotide C (blue peak).Figure 2Partial Electropherogram sequences of rs2487032 SNP for *ABCA1* gene in glaucoma patients. Forward primer was used here in PCR sequencing step. (**A**) A sample showing homozygous rs2487032 sequence variant genotype, which shows the conversion of nucleotide T (red peak) to nucleotide C (blue peak). (**B**) A sample showing heterozygous rs2487032 sequence variant genotype, which shows both nucleotide T (red peak) and nucleotide C (blue peak). (**C**) The wild type allele (T) of rs2487032 SNP for *ABCA1* gene.Figure 3Schematic structure of the human *ABCA1* gene. The positions of the two SNPs genotyped and their dbSNP IDs are also shown.

### Allelic And Genotyping Distribution Of Glaucoma Patients And Healthy Controls {#S0003-S2002-S3002}

Genotypic and allelic frequencies were estimated after analysing *ABCA1* SNPs. [Table 4](#T0004){ref-type="table"} shows the genetic association of two SNPs in the *ABCA1* gene in glaucoma patients by age adjustment. A group of biostatistical analysis was conducted to determine if the genotype frequency was significant. However, no significant differences were observed in the rs2472493 genotype and allele frequencies between glaucoma cases and controls (*P* = 0.71 for genotype and *P* = 0.696 for allele). In addition, no significant differences were observed in the rs2487032 genotype and allele frequencies between glaucoma cases and controls (*P* = 0.54 for genotype and *P* = 0.538 for allele). Genetic association analysis of the two SNPs genotyped in the glaucoma cases and controls was also conducted using dominant, additive, and recessive genetic models. For rs2472493, the common homozygous TT (*P* = 0.93), common heterozygous TC (*P* = 0.46), and rare homozygous CC (*P* = 0.51) were statistically significant (*P* \< 0.05). In contrast, for the other SNP, rs2487032, the common homozygous TT (*P* = 0.42), common heterozygous TC (*P* = 0.31), and rare homozygous CC (*P* = 0.92) were statistically significant (*P* \< 0.05). Moreover, [Table 5](#T0005){ref-type="table"} shows the genes which play an important role in primary open angle glaucoma. The table compares the patient's results with the controls in order to find a significant relationship between the variants and the glaucoma disease. The significance was determined according to the *P-*value; the level of significance taken as *p* \< 0.05.Table 4Genetic Association Of Two SNPs In The *ABCA1* Gene In Glaucoma Patients By Age AdjustmentSNP IDModelGenotypeAge \>35 N (%)Age ≤35 N (%)OR (95% CI)P-Valuers2472493CodominantT/T13 (36.1)5 (38.5)10.71C/T18 (50)5 (38.5)0.76 (0.18--3.20)C/C5 (13.9)3 (23.1)1.60 (0.27--9.47)DominantT/T13 (36.1)5 (38.5)10.93C/T-C/C23 (63.9)8 (61.5)0.94 (0.25--3.54)RecessiveT/T-C/T31 (86.1)10 (76.9)10.46C/C5 (13.9)3 (23.1)1.86 (0.37--9.31)OverdominantT/T-C/C18 (50)8 (61.5)10.51C/T18 (50)5 (38.5)0.65 (0.18--2.39)rs2487032CodominantT/T13 (36.1)3 (23.1)10.54C/T17 (47.2)6 (46.1)1.47 (0.30--7.08)C/C6 (16.7)4 (30.8)2.74 (0.46--16.49)DominantT/T13 (36.1)3 (23.1)10.42C/T-C/C23 (63.9)10 (76.9)1.80 (0.41--7.83)RecessiveT/T-C/T30 (83.3)9 (69.2)1.000.31C/C6 (16.7)4 (30.8)2.16 (0.49--9.47)OverdominantT/T-C/C19 (52.8)7 (53.9)1.000.92C/T17 (47.2)6 (46.1)0.93 (0.26--3.37) Table 5Genes, Which Play Important Role In Primary Open Angle GlaucomaGene symbolChromosomeSNP: p value, ORPhenotypePopulationReference*CAV1/CAV2*7q31rs4236601:\
p = 5 ×10^−10^,\
OR = 1.36POAGCaucasian**Thorleifsson** et al, 2010.[@CIT0020]rs1052990:\
p = 1.1 ×10^−9^, OR = 1.32(in Iceland)*TMCO1*1q24rs4656461:\
p = 6.1 ×10^−10^, OR = 1.68POAGCaucasian**Burdon** et al, 2011.[@CIT0019](in Australia)*CDKN2BAS*9p21rs1063192:\
p = 5.2 ×10^−11^, OR = 1.33POAGJapanese**Osman** et al, 2012.[@CIT0027]9p21rs4977756:\
p = 4.7 ×10^−9^, OR = 1.50POAGCaucasian**Burdon** et al, 2011.[@CIT0019](in Australia)9p21rs7865618:\
p = 9.0 ×10^−11^, OR = 1.78POAG/NTGJapanese**Nakano** et al, 2012.[@CIT0028]9p21rs2157719:\
p = 1.86 ×10^−18^, OR = 1.45POAGCaucasian**Wiggs** et al, 2012.[@CIT0011]*SIX1/SIX6*14q23rs10483727:\
p = 3.87 ×10^−11^, OR = 1.32POAGCaucasian**Wiggs** et al, 2012.[@CIT0011]*ABCA1*9q31.1rs2472493:\
p = 2.1× 10^−19^, OR = 1.31POAGAustralian**Gharahkhani** et al, 2014.[@CIT0025]

Discussion {#S0004}
==========

Glaucoma is a complex disorder affected by multiple genetic and environmental factors.[@CIT0022] Recent GWAS have focused on identifying genes associated with glaucoma. GWAS have been very effective in mapping disease susceptibility genes. In addition, susceptibility loci for glaucoma have been mapped in many different populations; some of which have been observed in multiple populations and some of which are unique to a specific population. To date, there is a lack of GWAS performed on Middle Eastern populations which gives little opportunity to elucidate more about the aetiology of common disease in these populations. Several genetic studies including candidate genes, linkage analysis studies, and GWAS approaches have identified several loci associated with development of POAG.[@CIT0007],[@CIT0011] Recently, a three-stage GWAS identify additional genetic loci associated with POAG in participant of European descent. These loci are located upstream of *ABCA1*, mainly within *AFAP1* and *GMDS* genes. All these genes are expressed within human retina, optic nerve, and trabecular meshwork.[@CIT0021] These studies were conducted using different populations with different strategies, and all identified the same gene (*ABCA1*), which is involved in the regulation of cellular cholesterol, lipid metabolism, and playing a role in the eye disease.[@CIT0023]

Furthermore, *ABCA1* gene is highly and specifically expressed in retinal ganglion cells having a role in the development of glaucoma.[@CIT0024] To the best of our knowledge, this study is the first in the field of ophthalmic genetics research in Jordan, and in Arab descent in general. It shows the genetic association analysis for *ABCA1* gene between 52 Jordanian patients with glaucoma and 96 healthy individuals. This cohort (N=148) was used to investigate the genetic association between variants in *ABCA1* gene and glaucoma risk. Previously, (rs2472493 and rs2487032) SNPs located upstream of the *ABCA1* gene on 9q31.1 were identified for being associated with POAG.[@CIT0024]--[@CIT0026] GWAS and meta-analysis of 18 population cohorts have discovered that rs2472493 was associated with POAG and elevated IOP.[@CIT0026] Meanwhile, Gharahkhani et al[@CIT0025] discovered similar results in Australia.

In addition, a significant genome-wide association of POAG (1007 cases) with elevated IOP (1009 controls) has been observed at multiple SNPs near *ABCA1* gene on 9q31.1 using subjects from southern China.[@CIT0024] Multiple population replications indicated that *ABCA1* gene might play a very important role in the process of POAG. On the other hand, a case-control study of the (rs2472493 and rs2487032) SNPs near the *ABCA1*gene among 1122 PACG subjects and 1311 healthy controls in a Han Chinese cohort showed no significant association in the distribution of allele frequencies in PACG,[@CIT0008] although they showed highly significant association in POAG.[@CIT0024]--[@CIT0026] Even though both PACG and POAG are subtypes of glaucoma, they share many similar clinical characteristics, but the genetic susceptibility might be different on the same candidate gene.[@CIT0008] In this study, we genotyped two SNPs located upstream of *ABCA1* gene (rs2472493 and rs2487032) in a Jordanian Arab glaucoma patients. As a result, the two reported SNPs showed no significant association in the distribution of the allele frequencies. On the contrary, they showed highly significant association in POAG from other ethnicities.[@CIT0024]--[@CIT0026] This could be due to the ethnic differences between populations which might have contributed to the genetic variation. This study included only Jordanian population which is considered as an isolated population. Moreover, the genetic heterogeneity of glaucoma disorder and the possibility of the involvement of other genes or environmental factors such as gene--gene interaction or gene--environmental interaction must be considered in further research.

Conclusion {#S0005}
==========

In conclusion, this study is the first genetic analysis of the *ABCA1* gene in Jordanian glaucoma patients. No previous studies have been conducted on *ABCA1* and its association with glaucoma in Arab nations. Herein, we relied on a sensitive sequencing technique for the genotyping process. The findings of this study proved that no association was observed between these SNPs and glaucoma in Jordanian Arab descent. This suggests that the genetic background of glaucoma in Jordanian Arab ethnicity and other ethnicities are different. Thus, further research with large sample size is needed to elucidate the exact mechanism of *ABCA1* in the progress of glaucoma in Jordan and Arab nation populations.
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[^1]: **Abbreviations:** Bp, base pair (Genomic Position); Chr, chromosome.

[^2]: **Notes:** \^Allele frequency and percent. The allele frequency might be counted twice in each person.

    **Abbreviation:** HWE, Hardy-Weinberg equilibrium.
